We fund pioneering research to improve survival rates and reduce the harm caused by brain tumours. This is led by our research strategy, with the most promising projects selected using rigorous peer review.
Our new Research Strategy defines our priorities over the next five years as we aim to create a world where brain tumours are defeated. The Strategy is led by patient, international professionals and key opinion leaders working in the field. All grant calls will focus on the research priorities higlighted in the strategy and all grant applications must address specifically the priority outlined in the call text.
Read A Cure Can't Wait: Our Research Strategy
We fund research through a fair, open and transparent process. This process is called peer review, recognised as best practice in awarding research grants. We are proud members of the Association of Medical Research Charities (AMRC), which governs this process.
Why peer review is essential
Peer review is recognised as best practice in awarding research grants, with each application subject to review by independent experts in the field. This process is followed by all major medical and health research charities in the UK. We are proud to be members of the Association of Medical Research Charities who govern this process and have twice been awarded a certificate in best practice for our peer review process.
The research and peer review process
Following an open, peer review process means we actively and publicly advertise our grant rounds and we follow an agreed strategy for the research we plan to fund – and make that public. Our new Research Strategy defines our priorities over the next five years as we aim to create a world where brain tumours are defeated.
The process differs for each type of grant but in every case we openly advertise for applications: for example, in relevant journals, on our and other websites and by contacting people on our mailing list which any academic is free to join. If you would like to be added, please send an email to email@example.com.
Every application is reviewed by external peer reviewers. We use online databases and existing contact lists to identify individuals from around the world with the most relevant expertise for each application. We ask them to comment on the suitability of the applicants' expertise, feasibility, the potential impact for people with brain tumours and the costs. Applicants then have an opportunity to respond to the reviews.
Following external peer review all applications, review forms and responses are sent to our Scientific Advisory Boards (SABs) who meet to discuss all the applications. The SABs are made up of internationally renowned scientific and medical experts that work in different areas of cancer research and social science. The two boards, Biomedical SAB and Quality of Life SAB, are responsible for the assessment and rating of applications for research funding and making recommendations to our board of Trustees
The final decisions about which projects to fund are made by our Trustees on the basis of the advice from the SABs.
If an applicant or grant holder has a query or concern relating to their application or grant they should contact our research team. Under no circumstances should they contact our SAB members or Trustees.
Throughout the process all information contained in applications, reviews and committee discussions is kept strictly confidential. We make every effort to ensure our decisions are fair, objective and transparent. Any individual who has a conflict of interest with an application is excluded from its assessment.